Showing 1 posts of 1 posts found.
PharmaSwiss is planning to build a brand new manufacturing unit in Belgrade, Serbia, to allow it to carry out end-to-end …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement